Brief: Shedir Pharma Announces Dymalife Pharmaceutical Acquired 3 Medicinal Products
Nov 20 (Reuters) - Shedir Pharma:
* ACQUISITION OF THREE MEDICINAL PRODUCTS: MESAFLOR®,
GENIAD® E
LISTEN®
* DYMALIFE PHARMACEUTICAL ACQUIRED 3 MEDICINAL PRODUCTS
WHICH
GENERATED GROSS MARGIN OF EUR 300,000 IN 2018, FOR A TOTAL OF
EUR 1.3M
* DYMALIFE PHARMACEUTICAL ACQUIRED REMAINING 50% OF MESAFLOR
AT A
MULTIPLE OF APPROXIMATELY 4.7 TIMES GROSS MARGIN
Source text for Eikon: ID:nBIA4h16q6
Further company coverage: SHE.MI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shedir Pharma Srl Unipersonale
See all newsBrief: Dimainvest Reaches 98.088% Of Shedir Pharma, Company To Delist On Jan 23
Brief: Shedir Pharma Says Subscription Period Ends For Dimainvest Offer
Italy - Factors to watch on Jan. 10
Brief: Dimainvest Says It Reached 90% Threshold In Shedir Pharma Takeover Bid
Brief: Dimainvest Launches Takeover Bid For Shedir Pharma